| 1.Stem cells (Dayton, Ohio)Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells.AuthorsMenon V,Thomas R,Elgueta C,Horl M,Osborn T,Hallett PJ,Bartos M,Isacson O,Pruszak J2.Molecular therapy. Nucleic acidsAn Efficient Bivalent Cyclic RGD-PIK3CB siRNA Conjugate for Specific Targeted Therapy against Glioblastoma InVitro and InVivo."11-0519 was used in Immunocytochemistry-immunoflourescence to reveal a great translational potential of biRGD-siPIK3CB conjugate as a novel molecule for glioblastoma therapy."AuthorsCen B,Wei Y,Huang W,Teng M,He S,Li J,Wang W,He G,Bai X,Liu X,Yuan Y,Pan X,Ji A3.ImmunologyInterferon-γ enhances both the anti-bacterial and the pro-inflammatory response of human mast cells to Staphylococcus aureus."11-0519 was used in Flow cytometry/Cell sorting to investigate the effect of interferon-γ on the biological responses of human mast cells to Staphylococcus aureus."AuthorsSwindle EJ,Brown JM,Rådinger M,DeLeo FR,Metcalfe DD4.Human reproduction (Oxford, England)Insulin-like growth factor 1 increases apical fibronectin in blastocysts to increase blastocyst attachment to endometrial epithelial cells in vitro."11-0519 was used in Flow cytometry/Cell sorting to study an increase in apical fibronectin in blastocysts mediated by insulin-like growth factor to increase blastocyst attachment to endometrial epithelial cells in vitro."5.Nucleic acids researchTumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA."11-0519 was used in Flow cytometry/Cell sorting to assess the anti-tumour potential of an siRNA molecule targetting VEGFR2 conjugated to cRGD peptide."AuthorsLiu X,Wang W,Samarsky D,Liu L,Xu Q,Zhang W,Zhu G,Wu P,Zuo X,Deng H,Zhang J,Wu Z,Chen X,Zhao L,Qiu Z,Zhang Z,Zeng Q,Yang W,Zhang B,Ji A |
QQ:1749072012